resiquimod has been researched along with angiotensinogen in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (angiotensinogen) | Trials (angiotensinogen) | Recent Studies (post-2010) (angiotensinogen) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 3,606 | 78 | 875 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briercheck, E; Butchar, JP; Byrd, JC; Caligiuri, M; Cheney, C; Dietsch, GN; Elavazhagan, S; Fang, H; Fatehchand, K; Gautam, S; Hershberg, RM; Mo, X; Reader, B; Ren, L; Santhanam, V; Tridandapani, S; Vasilakos, JP | 1 |
1 other study(ies) available for resiquimod and angiotensinogen
| Article | Year |
|---|---|
Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity.
Topics: Amino Acid Chloromethyl Ketones; Angiotensinogen; Antibodies, Monoclonal, Humanized; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; Blotting, Western; Cells, Cultured; Cetuximab; Cluster Analysis; Dose-Response Relationship, Drug; Granzymes; Humans; Imidazoles; Interleukin-2; Monocytes; NF-kappa B; Oligonucleotide Array Sequence Analysis; Perforin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Time Factors; Toll-Like Receptor 8; Transcriptome | 2015 |